STI Stock Trade Intelligence
LTP

LTR PHARMA LIMITED

Health Care · ASX:LTP
$0.4650
▲ +4.49%
Market cap
$85M
Turnover
$23,747
Last price
$0.4650
Day change
+4.49%
Announcements
15
Range, past year
Open 0.645 · Low 0.270 · Now 0.465 · High 0.810
Open LTP in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.

LTP momentum and trend analysis

Our analysis
Independent analysis generated by Stock Trade Intelligence as at 2026-09-28.
Momentum quality
25/100
Wyckoff phase
Accumulation1d
Trend stage
Neutral
1 Day
+4.5%
1 Week
-1.1%
1 Month
-1.1%
1 Year
-29.5%
RSI
49
Avg daily range
5.9%

LTR PHARMA LIMITED scores 25 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.

On the Wyckoff cycle it sits in Accumulation, where it has been for 1 trading day. The weekly timeframe reads Downtrend, which does not yet agree with the daily view.

Against the wider market it is currently underperforming and the institutional accumulation signal reads low.

Points to watch
  • 60d drawdown -27.2%
  • Thin liquidity
  • Risk rating: Very High
  • Composite downside risk elevated
LTP appears on this screen:
ASX stocks in Wyckoff accumulationASX momentum stocks by trend qualityASX stocks breaking outASX stocks near 52-week highs

LTP announcements

Recent price-sensitive releases.
  • 2026-08-28 Appendix 4E and Annual Report to Shareholders Annual Report | Top 20 shareholders | Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report
  • 2026-08-28 FY26 Results Announcement Preliminary Final Report
  • 2026-08-11 SPONTAN Real-World Study Reports 93% Response Progress Report
  • 2026-07-28 Quarterly Activities/Appendix 4C Cash Flow Report Commitments Test Entity - Fourth Quarter Activity Report | Commitments Test Entity - Fourth Quarter Cashflow Report
  • 2026-07-20 LTR Executes U.S. Commercial Agreement with Strive
  • 2026-07-17 LTR Executes Definitive U.S. Commercial Agreement with Shed
  • 2026-06-15 Response to ASX Aware Letter
Get the daily briefing The day's price-sensitive announcements, ranked by what actually moved, with our own momentum and cycle read on each.